UDG Healthcare-backed Sharp completed the acquisition of a 25% stake in Berkshire Sterile Manufacturing.

UDG Healthcare-backed Sharp, a provider of contract packaging and clinical services, completed the acquisition of a 25% stake in Berkshire Sterile Manufacturing, a provider of the sterile drug products possible for clinical use and small-scale commercial requirements. Financial terms were not disclosed. The deal follows BSM’s announcement of a $20m investment into expanding its filling capacity and capabilities. This expansion will double the company’s clean room and warehouse space, and bring a first-of-its-kind isolator-based robotic flexible sterile filling line. “Having Frank and Kevin join the BSM board as part of this deal will be greatly beneficial as the collaboration between our companies grows in the years to come. The agreement will also allow further collaboration in Quality, Project Management, IT, Logistics, Storage and Distribution and will enhance our respective integrated service offerings, reducing timelines and ultimately optimizing the client experience.” Shawn Kinney, Berkshire Sterile Manufacturing CEO.